Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06664697 · ClinicalTrials.gov registry record

Post-Market Clinical Investigation of the IotaSOFT Insertion System

A clinical trial of Hearing Loss, Sensorineural and Cochlear Implantation, sponsored by iotaMotion.

Recruiting
Registry status
50
Enrollment target
3
Study locations

NCT06664697 is a study of Hearing Loss, Sensorineural and Cochlear Implantation that is actively recruiting participants, run by iotaMotion. The registered enrollment target is 50 participants, below the 784-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (94% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06664697, a study of Hearing Loss, Sensorineural and Cochlear Implantation, is actively recruiting participants, sponsored by iotaMotion.

RECRUITING
Registry status
50 participants
Enrollment target
3
Study locations

Study Summary

The purpose of the proposed study is to evaluate the continued safety of the iotaSOFT Insertion System when used by a surgeon to assist with inserting a CI electrode array in one ear per subject

Interventions

  • DEVICE Cochlear Implantation with Robotic-Assisted Insertion System

Study Locations (3)

Indiana

  • Indiana University - Indianapolis

Iowa

  • University of Iowa - Iowa City

Oregon

  • Oregon Health and Sciences University - Portland

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-10-01
Est. Completion 2025-12-31

Sponsor

iotaMotion

4 total trials

What the Registry Record Tells You About NCT06664697

The ClinicalTrials.gov registry entry for NCT06664697 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 784-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (94% lower). The listed sponsor is iotaMotion, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hearing Loss, Sensorineural appearing as the primary indexed condition, and to 1 intervention - of which Cochlear Implantation with Robotic-Assisted Insertion System is the first listed.

NCT06664697 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Indiana, Iowa, Oregon.

Frequently Asked Questions

What is clinical trial NCT06664697 about?

NCT06664697 is a clinical study titled "Post-Market Clinical Investigation of the IotaSOFT Insertion System". The purpose of the proposed study is to evaluate the continued safety of the iotaSOFT Insertion System when used by a surgeon to assist with inserting a CI electrode array in one ear per subject

What is the current status of trial NCT06664697?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2024-10-01. Estimated completion is 2025-12-31.

What conditions does trial NCT06664697 study?

This clinical trial studies the following conditions: Hearing Loss, Sensorineural, Cochlear Implantation, Hearing Loss, Cochlear.

What interventions are being tested in trial NCT06664697?

The interventions under investigation include: Cochlear Implantation with Robotic-Assisted Insertion System (DEVICE).

Who is sponsoring clinical trial NCT06664697?

This trial is sponsored by iotaMotion, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06664697 being conducted?

This trial has 3 study locations across Indiana, Iowa, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Loss, Sensorineural

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.